In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1933 News Items found
Mother holding her newborn baby.
Cancer During Pregnancy: How MSK Protects Both Mother and Baby

Learn how MSK experts help navigate the special needs of people who have cancer during pregnancy
Tommy Ryan
How MSK Kids Helped a Teen With Aggressive Leukemia Recover After 150 Days in the Hospital

When Tommy Ryan was strong enough to go home after 150 days at MSK Kids, his father wrote to personally thank the dozens of MSK staff members who had supported their family through the toughest time in their lives.
Inside MSK’s Herbal Dispensary: Safe Herbal Medicine for Cancer Treatment Side Effects

Learn more about MSK’s Herbal Oncology Program, the first such program in the nation, offering patients safe and effective herbal remedies to relieve the side effects of cancer treatment.
What Are Cancer Ecosystems? How Cancer Cells Hijack Their Surroundings

MSK research is revealing how cancer cells are active architects of their environment — remaking their cellular neighborhood in their own image — and these insights are helping to develop new ways to fight back.
Patient receives a COVID-19 vaccine
2026–2027 COVID-19 Vaccine for People With Cancer & Others With Weakened Immune Systems

Memorial Sloan Kettering Cancer Center (MSK) recommends people with cancer stay up to date on their COVID-19 vaccinations. Cancer and its treatment can severely weaken the immune system, and people with cancer are particularly susceptible to severe COVID-19.
Dr. Alison Schram
FDA Approves Lirafugratinib for Treating Cholangiocarcinoma Caused by FGFR2 Mutations

The FDA has approved lirafugratinib for patients with advanced cholangiocarcinoma that carries an FGFR2 fusion or rearrangement, giving them a new option for targeted therapy.
Doctor rubbing down patient's arm with alcohol swab
Ask the Expert
Five Myths About the Flu Shot

MSK infectious disease specialist Monika Shah debunks common myths about the flu shot.
Sarah smiles in front of an MSK sign
How Genetic Cascade Testing Can Break the Cycle of Inherited Cancer Risk

Learn how the diagnosis of an inherited BRCA1 mutation is helping one family reduce its cancer risk.
Memorial Sloan Kettering infectious disease specialist Monika Shah
Q&A
What People With Cancer Should Know About the 2026–27 Flu Season

Learn why it's important to get a flu shot this year.
An MSK patient gets a vaccination from a healthcare provider
What To Know About the RSV Vaccines: Who Can Get Them, Side Effects, and Availability at MSK

RSV is a respiratory disease that spreads in the fall and winter months. Learn about the RSV vaccines. People ages 18 to 74 who are at risk for getting very sick from RSV should get vaccinated. Everyone ages 75 and older should get an RSV vaccine.